Skip to content
+91 22 42221111
compliance@sudarshanpharma.com
Search:
Sudarshan Pharma Industries Ltd.
Pharma and Specialty Chemicals
Home
Company Overview
About us
Business Model
Executive Leadership
Our Locations
Awards & Accolades
Corporate Presentation
Business Segments
Chemicals
Specialty Chemicals
Purification, LR, AR, material as per IP, BP, USP
Manufacturing
Pharmaceuticals
Ethical division
Generic Institution supply
Exports
Intermediates Manufacturing
API Manufacturing
API Contract Manufacturing
Inhalers Manufacturing
Investors/Disclosures under Reg 46 of LODR
Overview
Financial Information
Reports & Presentation
Disclosures
Board of Directors
Grievance Redressal
Business Details
Key Managerial Persons
Shareholding Pattern
SEBI (SAST) Regulations, 2011
SEBI (PIT) Regulations 2015
Investors Complaint
Other Investor Information
Codes and Policies
Investor Relation
Overview
Board Composition
Corporate Governance
Annual Reports
Financial Results
Statutory Disclosure
Initial Public Offering
Sustainability
Focus Areas
CSR
Media
Press Release
News & Events
Gallery
Clientele
Careers
People & Culture
Recruitment Process
Current Openings
Apply Now
Contact
Contact us
FAQ
Home
Company Overview
About us
Business Model
Executive Leadership
Our Locations
Awards & Accolades
Corporate Presentation
Business Segments
Chemicals
Specialty Chemicals
Purification, LR, AR, material as per IP, BP, USP
Manufacturing
Pharmaceuticals
Ethical division
Generic Institution supply
Exports
Intermediates Manufacturing
API Manufacturing
API Contract Manufacturing
Inhalers Manufacturing
Investors/Disclosures under Reg 46 of LODR
Overview
Financial Information
Reports & Presentation
Disclosures
Board of Directors
Grievance Redressal
Business Details
Key Managerial Persons
Shareholding Pattern
SEBI (SAST) Regulations, 2011
SEBI (PIT) Regulations 2015
Investors Complaint
Other Investor Information
Codes and Policies
Investor Relation
Overview
Board Composition
Corporate Governance
Annual Reports
Financial Results
Statutory Disclosure
Initial Public Offering
Sustainability
Focus Areas
CSR
Media
Press Release
News & Events
Gallery
Clientele
Careers
People & Culture
Recruitment Process
Current Openings
Apply Now
Contact
Contact us
FAQ
Investors Complaint
Click to View / Download respective document
Statement of Investors Grievance as on March, 2023
Go to Top
